MedTrace Logo

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT01441089 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2026-04-14

No results posted yet for this study

Summary

Background:

\- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.

Objectives:

\- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment.

Eligibility:

\- Individuals with cancer who are being treated at the National Cancer Institute.

Design:

* Participants will provide a blood sample for study.
* Participants who have blood-based cancer, such as leukemia, will provide a cheek swab sample.
* If the blood or cheek swab sample does not have enough genetic material for analysis, an additional sample may be collected.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • William D Figg, Pharm.D. · National Cancer Institute (NCI)

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01441089 on ClinicalTrials.gov